Сравнение

Linaclotid vs. Nafarelin

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

851199-59-2

нет данных

Молекулярная масса

1526.74 g/mol

нет данных

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Linaclotid

Linaclotide activates the guanylate cyclase-C receptor on the luminal surface of the intestinal epithelium. This raises cyclic GMP (cGMP), increases secretion of chloride and bicarbonate into the lumen, raises stool fluid content and accelerates transit; pain signaling is also modulated.

Nafarelin

Nafarelin is a potent GnRH agonist: after an initial stimulation ('flare'), continuous receptor occupancy leads to downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Linaclotid	Nafarelin
Германия	Рецептурный	Рецептурный
США	Рецептурный	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Linaclotid and Nafarelin?: Linaclotid is classified as "Исследования (прочее)", while Nafarelin is classified as "Исследования (прочее)". Linaclotid: Linaclotide is a 14-amino-acid peptide and guanylate cyclase-C (GC-C) agonist. It is approved for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). Nafarelin: Nafarelin is a GnRH agonist and the only member of this class delivered as a nasal spray. It is approved for treating endometriosis and central precocious puberty. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Linaclotid or Nafarelin?: The highest available evidence level is "РКИ на людях" for Linaclotid and "РКИ на людях" for Nafarelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Linaclotid and Nafarelin in Germany and the United States?: Германия: Linaclotid — Рецептурный, Nafarelin — Рецептурный. США: Linaclotid — Рецептурный, Nafarelin — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Linaclotid

Nafarelin

Германия

Рецептурный

США

Рецептурный

Frequently asked questions

What is the difference between Linaclotid and Nafarelin?

Linaclotid is classified as "Исследования (прочее)", while Nafarelin is classified as "Исследования (прочее)". Linaclotid: Linaclotide is a 14-amino-acid peptide and guanylate cyclase-C (GC-C) agonist. It is approved for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). Nafarelin: Nafarelin is a GnRH agonist and the only member of this class delivered as a nasal spray. It is approved for treating endometriosis and central precocious puberty. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Linaclotid or Nafarelin?

The highest available evidence level is "РКИ на людях" for Linaclotid and "РКИ на людях" for Nafarelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Linaclotid and Nafarelin in Germany and the United States?

Германия: Linaclotid — Рецептурный, Nafarelin — Рецептурный. США: Linaclotid — Рецептурный, Nafarelin — Рецептурный. These are factual summaries with source and review date on the individual pages.